Theranostics announced that the Phase 2b trial evaluating RAD101 imaging in brain metastases has achieved 50% patient enrollment ...
Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to ...
6d
ZAP Surgical's ZAP-Axon Radiosurgery Planning System Receives U.S. FDA 510(k) and E.U. CE Clearance
ZAP Surgical Systems, Inc., a pioneer in non-invasive robotic brain surgery, today announced that its award-winning ZAP-Axon(R) Radiosurgery Planning System has received both U.S. FDA 510(k) clearance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback